AlphaCrest Capital Management’s Globus Medical GMED Stock Holding History

AlphaCrest Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,919	Closed	-$233K	–	469
2022 Q3	$233K	Sell	3,919 -22,897	-85%	-$1.38M	0.01%	1209
2022 Q2	$1.5M	Buy	26,816 +12,111	+82%	+$796K	0.07%	473
2022 Q1	$1.08M	Buy	14,705 +994	+7%	+$69.1K	0.06%	512
2021 Q4	$990K	Sell	13,711 -1,117	-8%	-$81.1K	0.04%	793
2021 Q3	$1.14M	Sell	14,828 -1,173	-7%	-$94.2K	0.06%	561
2021 Q2	$1.24M	Sell	16,001 -12,476	-44%	-$887K	0.05%	557
2021 Q1	$1.76M	Buy	28,477 +18,480	+185%	+$1.17M	0.1%	300
2020 Q4	$652K	Sell	9,997 -8,088	-45%	-$465K	0.05%	503
2020 Q3	$896K	Sell	18,085 -453	-2%	-$23.4K	0.1%	300
2020 Q2	$884K	Buy	+18,538	New	+$894K	0.15%	182
2020 Q1	–	Sell	-4,758	Closed	-$280K	–	1115
2019 Q4	$280K	Sell	4,758 -2,812	-37%	-$153K	0.02%	1094
2019 Q3	$387K	Buy	+7,570	New	+$361K	0.02%	1027

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AlphaCrest Capital Management's GMED Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Globus Medical (GMED) in Q4 2022, closing a stake of 3,919 shares — an estimated $233K sold.

AlphaCrest Capital Management first reported a position in GMED in Q3 2019 and held it in 12 quarters. The position peaked at $1.76M in Q1 2021. 390 funds tracked by Wall St. Rank hold GMED as of Q4 2022.

AlphaCrest Capital Management reported no remaining Globus Medical position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 3,919 Globus Medical shares in Q4 2022, an estimated $233K.
AlphaCrest Capital Management first reported a position in Globus Medical in Q3 2019 and held it in 12 quarters.
AlphaCrest Capital Management's Globus Medical position peaked at $1.76M in Q1 2021.
390 funds tracked by Wall St. Rank held Globus Medical as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.